Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09WZU
|
||||
Former ID |
DNCL001927
|
||||
Drug Name |
BCI-838
|
||||
Indication | Alzheimer disease; Major depressive disorder [ICD9: 331, 296.2, 296.3, 710.0; ICD10:G30, F32, F33, M32] | Discontinued in Phase 1 | [523820] | ||
Company |
BrainCells
|
||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor 2 | Target Info | Modulator | [551197] | |
Metabotropic glutamate receptor3 | Target Info | Modulator | [551197] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Ionotropic glutamate receptor pathway | |||||
Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Metabotropic glutamate receptor group II pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.